US Department of Defense researchers to study spinal cord regeneration

Alan Condon -   Print  |

Biopharmaceutical company MicroCures partnered Feb. 19 with the Henry M. Jackson Foundation for the Advancement of Military Medicine to study spinal cord regeneration after trauma.

Researchers from the U.S. Department of Defense will evaluate MicroCures' lead product, siFi2, in animal models with spinal cord injuries. 

Intended to improve recovery after trauma, siFi2 is a small interfering ribonucleic acid therapeutic that is applied topically.

Spearheaded by Kimberly Byrnes, PhD, of the Uniformed Services University of the Health Sciences in Bethesda, Md., researchers will explore the use of siFi2 in driving axon regeneration and functional recovery.

More articles on biologics:
Stryker ranks No. 8 in Fortune's 100 best workplaces
Wuhan neurosurgeon, hospital director dies from coronavirus, death toll rises to 1,800+
Medtronic reports spine revenue up 3%, hurt by low BMP sales: 7 things to know

© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies here.

Featured Webinars

Featured Whitepapers